Trials / Completed
CompletedNCT06071104
Next Generation Cataract Surgery Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 121 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain device-specific safety and performance clinical data to support marketability in Europe and to collect user preference data.
Detailed description
Subjects will attend a screening visit (Day -60 to Day 0), a surgery visit (Day 0), and 3 post-surgical visits (Day 1, Week 1, Month 1) for an overall individual duration of up to 3 months. One eye (study eye) will be treated. This study will be conducted in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Anterior segment ophthalmic surgery | Cataract surgery during which the crystalline lens (often cloudy) is broken into small pieces and gently removed from the eye with suction (phacoemulsification) |
| DEVICE | UNITY VCS | UNITY Vitreoretinal Cataract System (VCS) with console, remote control, foot controller, UNITY Cataract FMS Pack, and UNITY Anterior Vitrectomy Kit |
Timeline
- Start date
- 2023-12-06
- Primary completion
- 2024-05-23
- Completion
- 2024-06-28
- First posted
- 2023-10-06
- Last updated
- 2025-06-04
- Results posted
- 2025-06-04
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06071104. Inclusion in this directory is not an endorsement.